Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in People Aged 18 Years or Above

NCT00920374 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00920374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00920374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in People Aged 18 Years or Above
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
June 16, 2009
Completion date
July 8, 2009
Enrollment
118 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

influenza